期刊文献+

六西格玛在临床生化检验质量控制中的应用 被引量:11

Six sigma theory's role in quality control of the clinical biochemical examination
原文传递
导出
摘要 目的运用标准化西格玛方法评价临床生化检验阶段性能,发现问题,指导质量改进。方法收集本实验室2013年-2015年室内质控和参加卫生部临床检验中心室间质评的数据,计算累计变异系数(CV)和累计偏倚(Bias),根据检验项目的 CV、Bias及总允许误差(TEa)计算西格玛值(σ),评价临床生化实验室检验阶段性能,并设计质量控制方案。计算QGI值,查找导致性能不佳的主要原因,指导质量改进。结果 3年的统计结果达到6σ的分别占48.3%、48.4%、46.7%,未达到3σ的分别占20.6%、17.2%、23.4%。3年的平均σ值分别为6.29、6.09、5.66。连续3年达到6σ值的检测项目有AMY、CK、MG、DBIL、IgG、PHOS。连续3年未达到3σ值的检测项目有Na、ALB、Cl、UREA。未达到3σ值的所有检测项目的 QGI值均<0.8,需要优先改进精密度。结论运用六西格玛理论能更为严谨的评价临床生化检验阶段性能,以此设计个体化的质量控制方案可更有效地指导质量改进。 Objective Apply the standard sigma metrics to assess the performance of clinical biochemical laboratory, then find problems and promote quality improvement. Methods We collected the data from internal quality control and participating in the ministry of health clinical inspection center's qualitative evaluation during 2013 - 2015. Then we calculated the cumulative variation coefficient(CV) and cumulative bias( Bias), according to the CV, Bias and total allowable error(TEa) of the test to calculate the Sigma value((r), to evaluate the performance of clinical biochemistry laboratory test, and to design the quality control plan. To calculate the QGI alue, and find out the main reasons leading to poor performance, so as to guide quality im- provement. Results The statistical results of three years to achieve 66 accounted for 48.3%, 48.4%, 46.7%, not reached 36 accounted for 20.6% , 17.2% and 23.4% , respectively. The average sigma value of the three years were 6.29, 6.09, 5.66, respectively. In the continuous three years, the test items achieved 66 included AMY, CK, MG, DBIL, IgG and PHOS, and not achieved 36 in the 3 years included Na, ALB, C1 and UREA. All the test items's QGI that did not achieve 36 were less than 0.8, so it need improve the precision priority. Conclusion Applying the six sigma theory, we can evaluate the clinical biochemical laboratory more rigorously. To design the individualized quality control scheme can more effectively guide the quali- ty improvement.
出处 《中国卫生检验杂志》 CAS 2017年第8期1122-1124,共3页 Chinese Journal of Health Laboratory Technology
基金 甘肃省省青年科技基金项目资助(1506RJYA247)
关键词 六西格玛 质量控制 质量改进 Six sigma Quality control Quality improvement
  • 相关文献

参考文献6

二级参考文献38

  • 1李萍,刘小娟,徐克和,黄志刚.利用Westgard标准决定图判定测定方法性能[J].临床检验杂志,2006,24(1):69-70. 被引量:27
  • 2王治国,李少男,王薇.临床检验方法评价决定图的制作及应用[J].检验医学,2006,21(6):570-572. 被引量:14
  • 3李园园,李萍,黄亨建.应用六西格玛理论评价临床实验室检验性能及设计质控方案[J].中国医疗器械信息,2007,13(6):9-11. 被引量:36
  • 4美.彼得 S.潘德,罗伯特 P.纽曼,罗兰 R.卡瓦纳.六西格玛管理法[M].刘合光,等译.北京:机械工业出版社,2005-03-01.
  • 5ISO 31000. Risk management-principles and guidelines[ S]. Interna- tional Organization for Standardization ,2009.
  • 6ISO/IEC Guide 73. Risk management-vocabulary [ S ]. Intenaational Organization for Standardization ,2009.
  • 7CLSI EP23-A. Laboratory quality control based on risk management; approved guideline [ S ]. Clinical and Laboratory Standards Institute, 2011.
  • 8ISO 15198. Clinical laboratory medicine-in vitro diagnostic medical devices-validation of user quality control procedures by the manufac- turer[S]. International Organization for Standardization, 2004.
  • 9Bonini P, Plebani M, Ceriotti F, et al. Errors in laboratory medicine [J]. Clin Chem,2002, 48(5) :691-698.
  • 10ISO 14971. Medical devices-application of risk management to medi- cal devices[S]. International Organization for Standardization,2007.

共引文献41

同被引文献75

引证文献11

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部